Publications by authors named "Latifatou Boukari"
The aim of this study was to determine the characteristics, treatment, and outcome according to each etiology of pachymeningitis.We conducted a retrospective multicenter French nationwide study between 2000 and 2016 to describe the characteristics, outcome, and treatment of pachymeningitis.We included 60 patients (median age 55.
View Article and Find Full Text PDFArticle Synopsis
- IVIG (intravenous immunoglobulins) may be a beneficial treatment for patients with systemic sclerosis (SSc) due to their immunomodulatory and antifibrotic effects.
- A study involving 46 SSc patients showed significant improvements in muscle pain, muscle weakness, and joint pain after IVIG treatment, along with reductions in inflammatory markers and corticosteroid usage.
- The treatment was generally safe, with few severe side effects reported, suggesting that IVIG could effectively manage symptoms and decrease reliance on corticosteroids in SSc patients.
A 56-year-old woman with ankylosing spondylitis, treated for 3 months with infliximab, developed miliary tuberculosis with mediastinal lymphadenopathies and brain and splenic lesions. After initial improvement under anti-tuberculous therapy, she suffered an unexpectedly prolonged paradoxical worsening with several episodes of lymphadenopathy, including life-threatening ones, over a period of more than 14 months of follow-up. The outcome was favorable as a result of corticosteroid and surgical treatments.
View Article and Find Full Text PDF